Aishwarya Krishnaraj

7PUBLICATIONS
26CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2026
Prevention of Vascular Aging as a Novel Paradigm for GLP-1 Receptor Agonist-Mediated Cardioprotection.

|Aug 31, 2025
Semaglutide promotes bone marrow-derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial.

Brady Park, Fallon Dennis, Arianna Z He

|Aug 29, 2025
Vascular regenerative deficiencies in people with elevated lipoprotein(a): the Lp(a)-VRCE CardioLink-16 translational study.

Michael Moroney, Jack H Casey, Hwee Teoh

|Jun 14, 2024
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes.

Brady Park, Aishwarya Krishnaraj, Hwee Teoh

|Mar 01, 2024
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage.

Brady Park, Ehab Bakbak, Hwee Teoh

|Sep 29, 2023
Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling.

Ehab Bakbak, Subodh Verma, Aishwarya Krishnaraj

Pageof 2

Frequent Collaborators

7 joint publications

Subodh Verma

7 joint publications

Hwee Teoh

6 joint publications

David A Hess

5 joint publications

Adrian Quan